136 related articles for article (PubMed ID: 8056893)
1. Production of overmodified type I procollagen in a case of osteogenesis imperfecta.
Tajima S; Takehana M; Azuma N
J Dermatol; 1994 Apr; 21(4):219-22. PubMed ID: 8056893
[TBL] [Abstract][Full Text] [Related]
2. Abnormal procollagen synthesis in fibroblasts from three patients of the same family with a severe form of osteogenesis imperfecta (type III).
Bonaventure J; Cohen-Solal L; Lasselin C; Allain JC; Maroteaux P
Biochim Biophys Acta; 1986 Oct; 889(1):23-34. PubMed ID: 3768427
[TBL] [Abstract][Full Text] [Related]
3. Type I procollagen in the severe non-lethal form of osteogenesis imperfecta. Defective pro-alpha 1(I) chains in a patient with abnormal proteoglycan metabolism and mineral deposits in the dermis.
Tenni R; Cetta G; Dyne K; Rossi A; Quacci D; Lenzi L; Castellani AA
Hum Genet; 1988 Jul; 79(3):245-50. PubMed ID: 3402997
[TBL] [Abstract][Full Text] [Related]
4. Abnormal alpha 2-chain in type I collagen from a patient with a form of osteogenesis imperfecta.
Byers PH; Shapiro JR; Rowe DW; David KE; Holbrook KA
J Clin Invest; 1983 Mar; 71(3):689-97. PubMed ID: 6826730
[TBL] [Abstract][Full Text] [Related]
5. The molecular defect in an autosomal dominant form of osteogenesis imperfecta. Synthesis of type I procollagen containing cysteine in the triple-helical domain of pro-alpha 1(I) chains.
de Vries WN; de Wet WJ
J Biol Chem; 1986 Jul; 261(19):9056-64. PubMed ID: 3722186
[TBL] [Abstract][Full Text] [Related]
6. Endoplasmic reticulum-mediated quality control of type I collagen production by cells from osteogenesis imperfecta patients with mutations in the pro alpha 1 (I) chain carboxyl-terminal propeptide which impair subunit assembly.
Lamandé SR; Chessler SD; Golub SB; Byers PH; Chan D; Cole WG; Sillence DO; Bateman JF
J Biol Chem; 1995 Apr; 270(15):8642-9. PubMed ID: 7721766
[TBL] [Abstract][Full Text] [Related]
7. Abnormal type I collagen metabolism by cultured fibroblasts in lethal perinatal osteogenesis imperfecta.
Bateman JF; Mascara T; Chan D; Cole WG
Biochem J; 1984 Jan; 217(1):103-15. PubMed ID: 6421277
[TBL] [Abstract][Full Text] [Related]
8. Defects in the processing of procollagen to collagen are demonstrable in cultured fibroblasts from patients with the Ehlers-Danlos and osteogenesis imperfecta syndromes.
Minor RR; Sippola-Thiele M; McKeon J; Berger J; Prockop DJ
J Biol Chem; 1986 Jul; 261(21):10006-14. PubMed ID: 3733683
[TBL] [Abstract][Full Text] [Related]
9. Osteogenesis imperfecta type IV: evidence of abnormal triple helical structure of type I collagen.
Wenstrup RJ; Hunter AG; Byers PH
Hum Genet; 1986 Sep; 74(1):47-53. PubMed ID: 3759085
[TBL] [Abstract][Full Text] [Related]
10. Type 1 collagen synthesis by skin fibroblasts from 17 patients with osteogenesis imperfecta type III.
Pocock AE; Francis MJ; Smith R
Clin Chim Acta; 1995 Dec; 243(1):53-72. PubMed ID: 8747514
[TBL] [Abstract][Full Text] [Related]
11. Localization of a structural defect in type I procollagen in a patient affected with the severe non-lethal form of Osteogenesis imperfecta.
Dyne K; Cetta G; Tenni R; Rossi A; Finardi E; Brunelli PC; Castellani AA
Ital J Biochem; 1987; 36(4):256-66. PubMed ID: 3429209
[TBL] [Abstract][Full Text] [Related]
12. BiP binds type I procollagen pro alpha chains with mutations in the carboxyl-terminal propeptide synthesized by cells from patients with osteogenesis imperfecta.
Chessler SD; Byers PH
J Biol Chem; 1993 Aug; 268(24):18226-33. PubMed ID: 8349698
[TBL] [Abstract][Full Text] [Related]
13. Collagen metabolism in cultured osteoblasts from osteogenesis imperfecta patients.
Mörike M; Brenner RE; Bushart GB; Teller WM; Vetter U
Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):73-7. PubMed ID: 1520286
[TBL] [Abstract][Full Text] [Related]
14. Reduced secretion of structurally abnormal type I procollagen in a form of osteogenesis imperfecta.
Barsh GS; Byers PH
Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5142-6. PubMed ID: 6946461
[TBL] [Abstract][Full Text] [Related]
15. Studies on type I collagen in skin fibroblasts cultured from twins with lethal osteogenesis imperfecta.
Galicka A; Wołczyński S; Gindzieński A
Acta Biochim Pol; 2003; 50(2):481-8. PubMed ID: 12833172
[TBL] [Abstract][Full Text] [Related]
16. A defect in the structure of type I procollagen in a patient who had osteogenesis imperfecta: excess mannose in the COOH-terminal propeptide.
Peltonen L; Palotie A; Prockop DJ
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6179-83. PubMed ID: 6934545
[TBL] [Abstract][Full Text] [Related]
17. Collagen defects in lethal perinatal osteogenesis imperfecta.
Bateman JF; Chan D; Mascara T; Rogers JG; Cole WG
Biochem J; 1986 Dec; 240(3):699-708. PubMed ID: 3827862
[TBL] [Abstract][Full Text] [Related]
18. Expression of mutant alpha (I)-procollagen in osteoblast and fibroblast cultures from a proband with osteogenesis imperfecta type IV.
Chipman SD; Shapiro JR; McKinstry MB; Stover ML; Branson P; Rowe DW
J Bone Miner Res; 1992 Jul; 7(7):793-805. PubMed ID: 1642148
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of the gene for the pro alpha 1(IV) chain of basement-membrane procollagen in cultured skin fibroblasts from two variants of osteogenesis imperfecta.
Pihlajaniemi T; McKeon J; Gay S; Gay R; de Wet WJ; Myers JC; Prockop DJ
Biochem J; 1989 Jan; 257(2):439-45. PubMed ID: 2649075
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the carboxyl-terminal propeptide of the pro alpha 1(I) chain of type I collagen result in defective chain association and produce lethal osteogenesis imperfecta.
Chessler SD; Wallis GA; Byers PH
J Biol Chem; 1993 Aug; 268(24):18218-25. PubMed ID: 8349697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
